Addex Historical Valuation

Stocks . USA . 
Stock . Addex Therapeutics
ADXN Stock  USD 1.13  0.05  4.63%   
Some fundamental drivers such as market cap or Addex Therapeutics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Addex Therapeutics valuation indicators such as Average Equity of 17.2 M or Enterprise Value of 10.6 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Addex Therapeutics's future value. Financial Statement Analysis is much more than just reviewing and breaking down Addex Therapeutics prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Addex Therapeutics is a good buy for the upcoming year.
Check out Trending Equities. To learn how to invest in Addex Stock please use our How to Invest in Addex Therapeutics guide.
  

About Addex Valuation Data Analysis

Valuation is the financial process of determining what Addex Therapeutics is worth. Addex Therapeutics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Addex Therapeutics valuation ratios help investors to determine whether Addex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Addex with respect to the benefits of owning Addex Therapeutics security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details

Addex Therapeutics Valuation Data Chart

Addex valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of Addex equity instrument and the benefits of owning shares of Addex Therapeutics.
Addex Therapeutics Average Assets are very stable at the moment as compared to the past year. Addex Therapeutics reported last year Average Assets of 20.03 Million. As of 29th of March 2023, Average Equity is likely to grow to about 17.2 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (14.5 M).
Average Assets  Enterprise Value  Market Capitalization  
Add Fundamental

Average Assets

Average asset value for the period used in calculation of Return on Average Equity and Return on Average Assets; derived from Total Assets.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Addex Therapeutics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Addex Therapeutics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Addex Therapeutics value than its market capitalization because it takes into account all of Addex Therapeutics existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Market Capitalization

Market capitalization (or market cap) is the total value of the shares outstanding of Addex Therapeutics. It is equal to Addex Therapeutics current share price times the number of Addex Therapeutics outstanding shares. Represents the product of [SharesBas]; [Price] and [ShareFactor].
Most indicators from Addex Therapeutics' valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into Addex Therapeutics current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities. To learn how to invest in Addex Stock please use our How to Invest in Addex Therapeutics guide.Addex Therapeutics Average Assets are very stable at the moment as compared to the past year. Addex Therapeutics reported last year Average Assets of 20.03 Million. As of 29th of March 2023, Average Equity is likely to grow to about 17.2 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop (14.5 M).
 2021 2022 2023 (projected)
Enterprise Value11.51 M10.36 M10.63 M
Average Equity16.85 M15.16 M17.17 M

Addex Therapeutics valuation accounts Correlations

Click cells to compare fundamentals

Addex Therapeutics Account Relationship Matchups

High Positive Relationship

Market Capitalization
Enterprise Value
Working Capital
Tangible Asset Value
Free Cash Flow
Earnings before Tax
Average Equity
Average Assets
Free Cash Flow
Enterprise Value
Market Capitalization
Free Cash Flow

High Negative Relationship

Invested Capital Average
Average Equity
Invested Capital Average
Average Assets
Invested Capital
Average Assets
Tangible Asset Value
Invested Capital
Working Capital
Invested Capital
Invested Capital
Average Equity

Addex Therapeutics valuation accounts Accounts

201820192020202120222023 (projected)
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(1.42 M)(14.23 M)(11.83 M)(14.94 M)(13.45 M)(14.51 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(1.45 M)(14.67 M)(13.44 M)(16.42 M)(14.78 M)(15.94 M)
Earnings before Tax(1.64 M)(14.78 M)(12.86 M)(15.35 M)(13.82 M)(14.91 M)
Free Cash Flow1.74 M(9.51 M)(12.24 M)(14.74 M)(13.26 M)(13.61 M)
Invested Capital(1.79 M)(3.64 M)(1.57 M)(1.6 M)(1.44 M)(1.55 M)
Tangible Asset Value42.21 M33.03 M20.18 M22.54 M25.92 M27.66 M
Working Capital39.82 M26.71 M15.87 M17.81 M20.48 M22.56 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Addex Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Addex Therapeutics

-0.65ABIOARCA Biopharma Fiscal Quarter End 31st of March 2023 PairCorr
-0.58ACLXArcellx Financial Report 11th of May 2023 PairCorr
-0.55ABEOAbeona Therapeutics Earnings Call TodayPairCorr
-0.49ABTIAlterola BiotechPairCorr
-0.46ABCMAbcamPLCPairCorr
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities. To learn how to invest in Addex Stock please use our How to Invest in Addex Therapeutics guide. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for analysis

When running Addex Therapeutics price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEO Directory
Screen CEOs from public companies around the world
Transaction History
View history of all your transactions and understand their impact on performance
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.45) 
Revenue Per Share
0.186
Quarterly Revenue Growth
(0.45) 
Return On Assets
(0.88) 
Return On Equity
(2.03) 
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Addex Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY